Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (871-880 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|February 23, 2019
Capture and display of antibodies secreted by hybridoma cells enables fluorescent on-cell screeningRama Devudu Puligedda, Rashmi Sharma, Fetweh H Al-Saleem, et al.
Mabs|August 13, 2019
Measuring the effects of macromolecular crowding on antibody function with biolayer interferometryDorothy M Kim, Xiao Yao, Ram P Vanam, et al.
Mabs|August 13, 2019
Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefitJie Wang, Keke Fei, Hua Jing, et al.
Mabs|January 18, 2021
Antibodies to watch in 2021Hélène Kaplon, Janice M Reichert
Mabs|January 15, 2022
Antibodies to watch in 2022Hélène Kaplon, Alicia Chenoweth, Silvia Crescioli, et al.
Mabs|January 18, 2022
In silico prediction of post-translational modifications in therapeutic antibodiesShabdita Vatsa
Mabs|January 11, 2022
Beyond bispecificity: Controlled Fab arm exchange for the generation of antibodies with multiple specificitiesDesislava Yanakieva, Lukas Pekar, Andreas Evers, et al.
Mabs|March 21, 2019
Hydrogen/deuterium exchange-mass spectrometry analysis of high concentration biotherapeutics: application to phase-separated antibody formulationsYuwei Tian, Lihua Huang, Brandon T Ruotolo, et al.
Mabs|March 21, 2019
Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapyHongchuan Liu, Lijing Guo, Jing Zhang, et al.
Mabs|February 14, 2012
Which are the antibodies to watch in 2012?Janice M Reichert
Pageof 184

Showing results (871-880 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|February 23, 2019
Capture and display of antibodies secreted by hybridoma cells enables fluorescent on-cell screeningRama Devudu Puligedda, Rashmi Sharma, Fetweh H Al-Saleem, et al.
Mabs|August 13, 2019
Measuring the effects of macromolecular crowding on antibody function with biolayer interferometryDorothy M Kim, Xiao Yao, Ram P Vanam, et al.
Mabs|August 13, 2019
Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefitJie Wang, Keke Fei, Hua Jing, et al.
Mabs|January 18, 2021
Antibodies to watch in 2021Hélène Kaplon, Janice M Reichert
Mabs|January 15, 2022
Antibodies to watch in 2022Hélène Kaplon, Alicia Chenoweth, Silvia Crescioli, et al.
Mabs|January 18, 2022
In silico prediction of post-translational modifications in therapeutic antibodiesShabdita Vatsa
Mabs|January 11, 2022
Beyond bispecificity: Controlled Fab arm exchange for the generation of antibodies with multiple specificitiesDesislava Yanakieva, Lukas Pekar, Andreas Evers, et al.
Mabs|March 21, 2019
Hydrogen/deuterium exchange-mass spectrometry analysis of high concentration biotherapeutics: application to phase-separated antibody formulationsYuwei Tian, Lihua Huang, Brandon T Ruotolo, et al.
Mabs|March 21, 2019
Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapyHongchuan Liu, Lijing Guo, Jing Zhang, et al.
Mabs|February 14, 2012
Which are the antibodies to watch in 2012?Janice M Reichert
Pageof 184